Amicus Therapeutics Announces First Quarter 2023 Financial Results, Corporate Updates - MyChesCo
PHILADELPHIA, PA — Amicus Therapeutics (Nasdaq: FOLD) this week announced financial results for the first quarter ended March 31, 2023. Bradley Campbell, President and Chief Executive Officer of Amicus Therapeutics, …
MyChesCo
